BackLux Health Tech Acquisition - Warrants(30/11/2027) Overview
Lux Health Tech Acquisition Corp - Warrants(30/11/2027)

Lux Health Tech Acquisition - Warrants(30/11/2027) Return on Equity

Latest ROE for Lux Health Tech Acquisition - Warrants(30/11/2027): -213.75% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-213.75%

Return on Equity

-213.75%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Lux Health Tech Acquisition - Warrants(30/11/2027) (LUXAW) FAQ

Lux Health Tech Acquisition - Warrants(30/11/2027) posts a ROE of -213.75%. That is below the sector sector average of -5.68%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near -5.68% is typical. Lux Health Tech Acquisition - Warrants(30/11/2027)'s -213.75% is lower that level. That is roughly 3661.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Lux Health Tech Acquisition - Warrants(30/11/2027)'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -213.75%; use YoY and peer views to separate noise from signal.

Context for LUXAW's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -5.68%), and (3) consistency with growth and profitability. This page covers the first two; Lux Health Tech Acquisition - Warrants(30/11/2027)'s other metric pages and overview cover the third.